Scarica l'app Stockscreener
1.61
1.90%
0.03
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Inovio Pharmaceuticals Inc Borsa (INO) Ultime notizie
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Plug Power Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – PLUG - GlobeNewswire Inc.
ROSEN, A LEADING LAW FIRM, Encourages Inovio Pharmaceuticals Inc. Investors to Secure Counsel ... - Bluefield Daily Telegraph
INO SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors ... - Bluefield Daily Telegraph
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Inovio Pharmaceuticals Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionINO - ACCESS Newswire
DEADLINE ALERT for TCPC, ORCL, PSFE, and INO: The Law - GlobeNewswire
Forecast Cut: What’s next for Inovio Pharmaceuticals Inc. stockJuly 2025 Highlights & Daily Market Momentum Tracking - mfd.ru
2026-02-13 | INO SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Inovio Pharmaceuticals, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! | NDAQ:INO | Press Release - Stockhouse
ROSEN, LEADING INVESTOR COUNSEL, Encourages Inovio Pharmaceuticals Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionINO - ACCESS Newswire
INO DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026 - ACCESS Newswire
Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain OfficersINO - PR Newswire
Securities Fraud Investigation Into Inovio Pharmaceuticals, Inc. (INO) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm - marketscreener.com
Inovio Pharmaceuticals Under Investigation for Possible Securities Law Violations - Intellectia AI
FinancialContentInovio Pharmaceuticals, Inc. (INO) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation - FinancialContent
Securities Fraud Investigation Into Inovio Pharmaceuticals, Inc. (INO) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - The AI Journal
Portnoy Law Firm Announces Class Action on Behalf of Inovio Pharmaceuticals, Inc. Investors - GlobeNewswire
Bronstein, Gewirtz & Grossman LLC Urges Inovio - GlobeNewswire
INOVIO to Participate in Multiple Scientific and Investor Conferences - Intellectia AI
Published on: 2026-02-12 16:56:02 - mfd.ru
INOVIO to Participate in Upcoming Scientific and Investor Conferences - Finviz
Inovio Pharmaceuticals Faces Class Action for Securities Fraud - Intellectia AI
User - The Chronicle-Journal
Is Inovio Pharmaceuticals Inc. stock good for income investorsQuarterly Portfolio Review & Breakout Confirmation Alerts - mfd.ru
INOVIO CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswire
INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Business Wire
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Inovio - GlobeNewswire
INO SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026 - The Malaysian Reserve
Will Inovio Pharmaceuticals Inc. stock see PE expansion2025 Investor Takeaways & Expert Curated Trade Setup Alerts - mfd.ru
INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, I - GuruFocus
IINO Stockholder Alert: Robbins LLP Reminds Investors of the Class Action Against Inovio Pharmaceuticals, Inc. - PR Newswire
INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit - InsideNoVa.com
INO INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Inovio Pharmaceuticals, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
DNA Nanotechnology Market Growth in Future Scope 2026-2033 - openPR.com
Rosen Law Firm Urges Inovio Pharmaceuticals, Inc. (NASDAQ: INO) Stockholders to Contact the Firm for - PharmiWeb.com
Rosen Law Firm Urges Inovio Paysafe Limited (NASDAQ: PSFE) Stockholders to Contact the Firm for Information About Their Rights - Business Wire
Inovio Pharmaceuticals Faces Class Action for Misleading Investors - Intellectia AI
Rosen Law Firm Urges Inovio Pharmaceuticals, Inc. (NASDAQ: INO) Stockholders to Contact the Firm for Information About Their Rights - Bluefield Daily Telegraph
Inovio Pharmaceuticals Faces Class Action Lawsuit Over Misleading Statements - Intellectia AI
Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the Inovio Pharmaceuti - PharmiWeb.com
Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the Inovio Pharmaceuticals, Inc. Class Action Lawsuit - Business Wire
Aug Sentiment: Is Inovio Pharmaceuticals Incs ROE strong enoughJuly 2025 Opening Moves & Risk Managed Investment Strategies - baoquankhu1.vn
INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of - GlobeNewswire
Stock Report: Is Inovio Pharmaceuticals Incs ROE strong enoughTrade Performance Summary & High Conviction Trade Alerts - baoquankhu1.vn
Risk Recap: Is Inovio Pharmaceuticals Inc a turnaround storyRate Cut & Daily Profit Focused Stock Screening - baoquankhu1.vn
Inovio Pharmaceuticals (INO) Price Target Increased by 12.14% to 8.73 - Nasdaq
Pomerantz LLP Investigates Inovio Securities Fraud Claims - Intellectia AI
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio Pharmaceuticals, Inc. - GlobeNewswire Inc.
Is Inovio Pharmaceuticals Inc a potential multi baggerEarnings Overview Report & Daily Stock Trend Watchlist - baoquankhu1.vn
Market Trends: What is the implied volatility of Match Group IncMarket Weekly Review & Comprehensive Market Scan Reports - baoquankhu1.vn
Guidance Update: Is Inovio Pharmaceuticals Inc a top pick in the sectorForecast Cut & AI Optimized Trading Strategy Guides - baoquankhu1.vn
Is Inovio Pharmaceuticals Inc.’s ROIC above industry average2025 Dividend Review & Free Long-Term Investment Growth Plans - mfd.ru
Market Sentiment Around Loss-Making Inovio Pharmaceuticals, Inc. (NASDAQ:INO) - Yahoo Finance
Investment Report: What are TIGRs recent SEC filings showingShare Buyback & Community Consensus Picks - baoquankhu1.vn
Inovio Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Inovio Extends Series A Warrants, Enhancing Capital Flexibility - TipRanks
Inovio (NASDAQ: INO) extends Series A warrant expiration to March 31, 2026 - stocktitan.net
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
DNA Vaccines Market to Reach US$ 6.82 Billion by 2033 at 18.5% - openPR.com
S P Trends: What are Inovio Pharmaceuticals Incs growth levers2025 Price Targets & Verified Stock Trade Ideas - baoquankhu1.vn
INO-3107 At The Crossroads: FDA Review Drives Inovio's Upside And Risk (NASDAQ:INO) - Seeking Alpha
1.12%
0.87%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):